TABLE 4.

Baseline and 28-Day Physiologic Parameters of Studied Infants

Outcome CharacteristicEnrollment28 d
PlaceboFluticasoneP ValuePlaceboFluticasoneP Value
Weight, g1282 ± 4211421 ± 732.511944 ± 9532029 ± 917.77
Height, cm39.0 ± 2.739.9 ± 5.2.6142 ± 3.742.3 ± 5.4.88
Head circumference, cm28.0 ± 2.127.6 ± 2.8.7031.1 ± 2.131.4 ± 3.8.79
Blood glucose, mmol/L4.8 ± 0.85.2 ± 0.6.125.4 ± 1.15.6 ± 0.8.56
Cortisol/creatinine ratio, nmol/mmol52.6 ± 30.449.8 ± 36.1.8543 ± 14.425.1 ± 18.9*.06
Arterial blood pressure
    Systolic, mm Hg67 ± 368 ± 3.3.8371 ± 2.578 ± 3.4.16
    Diastolic, mm Hg37 ± 1.838 ± 2.0.2538 ± 3.043 ± 3.4.21
Chest radiograph score2.6 ± 1.53.7 ± 2.2.152.8 ± 2.22.8 ± 1.4§.50
  • * P = .06, fluticasone baseline vs 28 days, paired t test.

  • P = .04, fluticasone baseline vs 28 days, paired t test.

  • P = .03, fluticasone baseline vs 28 days, paired t test.

  • § P = .04, fluticasone baseline vs 28 days, paired t test.